The etiology of prostate cancer or of benign prostatic hyperplasia (BP
H) is essentially not understood. It is becoming clear, however, that
major determinants of the malignant or hyperplastic phenotype are vari
ous growth-stimulatory or -inhibitory factors and their receptors, who
se inappropriate expression or loss disrupts normal regulation of cell
proliferation and differentiation. Cell culture has been a versatile
tool for studying the expression and interaction of growth factors in
prostatic cells. Immunohistochemistry and in situ hybridization have p
rovided a view of growth factor expression coupled with histopathology
. The eventual definition of autocrine, paracrine, and endocrine pathw
ays of growth regulation in the human prostate will facilitate the des
ign of new preventative, diagnostic, and therapeutic strategies. (C) 1
996 Wiley-Liss, Inc.